Sling Therapeutics hires new CCO
ANN ARBOR–Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease, announced the appointment of Ken Lock as …
New CEO at Courage Therapeutics
ANN ARBOR–Courage Therapeutics, a biopharma company developing new treatments for obesity and eating disorders, today announced the appointment of Giovanni Ferrara as its new CEO. This announcement follows an investment …
FDA approves cancer drug trial for Grosse Pointe Farms firm
GROSSE POINTE FARMS–SciTech Development Inc., a clinical-stage oncology drug development company, announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for a Phase …
Pharma startup announces next stage of clinical trial for new cancer drug
GROSSE POINTE FARMS—SciTech Development LLC, a clinical-stage pharmaceutical company specializing in oncology, announced the initiation of the next stage of its clinical trial for their lead drug candidate, ST-001 nanoFenretinide. …
Evoq Therapeutics secures $2M in NIH funding
ANN ARBOR—The autoimmune disease pharma startup Evoq Therapeutics announced it had received a $2 million grant from the National Institutes of Health to advance novel therapies for autoimmune diseases. “We …
MMS hires chief commercial officer
CANTON TWP.–MMS, a data-focused clinical research organization, announced that Ben Dudley has been appointed as the company’s new chief commercial officer. Dudley brings more than 25 years of life sciences …
TrialAssure launches Anonymize 3.0 for improved data, document anonymization in pharma and beyond
CANTON TWP.–TrialAssure, a pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure Anonymize 3.0 is now available. Anonymize allows users across the …
Esperion, Daiichi Sankyo Europe settle litigation
ANN ARBOR–Esperion Therapeutics Inc. (NASDAQ: ESPR) and Daiichi Sankyo Europe GmbH, the Europe-based organization of the Japanese pharmaceutical company Daiichi Sankyo Co. Ltd., announced a $125 million amendment to their collaboration, which …
Caeregen wins $1.4M SBIR grant for new eye drug
ROCHESTER–Caeregen Therapeutics announced that it has been awarded a $1.4 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health and its National Eye Institute to …
LSPedia, Pharmasource in partnership
WEST BLOOMFIELD TWP.–LSPedia, a software-as-a-service provider specializing in product traceability for the pharmaceutical industry, announced a strategic partnership with Pharmsource, a wholesale distributor in Sunrise, Fla. This collaboration aims to …